The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Sumoylation increases HIF-1α stability and its transcriptional activity
Abstract
HIF-1 is closely involved in various biological processes, including angiogenesis, energy metabolism, and cell survival. HIF-1 consists of an oxygen-sensitive HIF-1alpha and oxygen-insensitive HIF-1beta. Oxygen-sensitive HIF-1alpha is subjected to post-translational modifications such as hydroxylation, ubiquitination, and acetylation, which are related to the regulation of its stability. In this present study, we found that the ectopic expression of SUMO-1 increased HIF-1alpha stability by the co-transfection study with HIF-1alpha and SUMO-1. Furthermore, the ectopic expression of SUMO-1 enhanced the transcriptional activity of HIF-1alpha. In the subsequent immunoprecipitation assay, SUMO-1 was co-immunoprecipitated with HIF-1alpha, implying that HIF-1alpha is covalently modified by SUMO-1. Thereafter, using a series of lysine mutants in the ODD domain, we found that HIF-1alpha was sumoylated at Lys(391) and Lys(477), suggesting that sumoylation at these two lysine residues enhances HIF-1alpha stability by possibly modulating other post-translational modifications. Altogether, we demonstrate that HIF-1alpha is upregulated through SUMO-1 modification at Lys(391)/Lys(477) residues, which may stabilize HIF-1alpha and enhance its transcriptional activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because SUMOylation enhances both the stability and transcriptional activity of HIF-1α [190], altered SUMO conjugation may contribute to reduced HIF-1α protein levels.”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [190]
In the citing paper
“Because SUMOylation enhances both the stability and transcriptional activity of HIF-1α [190], altered SUMO conjugation may contribute to reduced HIF-1α protein levels.”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [190]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Flagged first, then by citations
Cited by
Sorted by citations
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Hypoxia-Induced Angiogenesis: Good and Evil
Krock, B. L., Skuli, N., & Simon, M. C. (2011) · Genes & Cancer · doi:10.1177/1947601911423654 · Cited by 1,236
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 816
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia
Cheng, J., Kang, X., Zhang, S., & Yeh, E. T. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.045 · Cited by 624
The use of cobalt chloride as a chemical hypoxia model
Muñoz‐Sánchez, J., & Chánez‐Cárdenas, M. E. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3749 · Cited by 535
The effect of HIF on metabolism and immunity
Taylor, C. T., & Scholz, C. C. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00587-8 · Cited by 517
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477
HIF-1 regulation: not so easy come, easy go
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.002 · Cited by 339
Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation
Herrmann, J., Lerman, L. O., & Lerman, A. (2007) · Circulation Research · doi:10.1161/01.res.0000264500.11888.f0 · Cited by 332
Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318
Hypoxia-inducible factors and the regulation of lipid metabolism
Mylonis, I., Simos, G., & Paraskeva, E. (2019) · Cells · doi:10.3390/cells8030214 · Cited by 316
Matić, I., van Hagen, M., Schimmel, J., Maček, B., Ogg, S. C., Tatham, M. H., Hay, R. T., Lamond, A. I., Mann, M., & Vertegaal, A. C. O. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700173-mcp200 · Cited by 310
NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α
Kim, T., Hur, E.-G., Kang, S., Kim, J., Thapa, D., Lee, Y. M., Ku, S., Jung, Y., & Kwak, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3007 · Cited by 292
Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
Webb, J. D., Coleman, M. L., & Pugh, C. W. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0147-7 · Cited by 261
An additional role for SUMO in ubiquitin-mediated proteolysis
Geoffroy, M., & Hay, R. T. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2707 · Cited by 250
Sumoylation regulates diverse biological processes
Zhao, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7137-4 · Cited by 248
Li, J., Xu, Y., Long, X., Wang, W., Jiao, H., Mei, Z., Yin, Q., Ma, L., Zhou, A., Wang, L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.008 · Cited by 247
Turn me on: regulating HIF transcriptional activity
Lisy, K., & Peet, D. J. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402315 · Cited by 248
Regulatory mechanisms of hypoxia‐inducible factor 1 activity: Two decades of knowledge
Koyasu, S., Kobayashi, M., Gotö, Y., Hiraoka, M., & Harada, H. (2017) · Cancer Science · doi:10.1111/cas.13483 · Cited by 233
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 217
Reactive oxygen species and HIF-1 signalling in cancer
Galanis, Α., Pappa, A., Giannakakis, A., Lanitis, E., Laniti, D. D., & Sandaltzopoulos, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.028 · Cited by 210
SENP3 is responsible for HIF‐1 transactivation under mild oxidative stress via p300 de‐SUMOylation
Huang, C., Han, Y. Y., Wang, Y., Sun, X., Yan, S., Yeh, E. T. H., Chen, Y., Cang, H., Li, H., Shi, G., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.210 · Cited by 218
Cancer Drug Discovery and Development
Humphrey, J. S., Price, K., Gupta, E., Baxter, A. R. W., Bird, J., Sonnichsen, D. S., & Naglich, J. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-325-5_21 · Cited by 195
Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Zhang, Z., Yan, J., Chang, Y. Z., Yan, S., & Shi, H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200426 · Cited by 190
HIF in Kidney Disease and Development
Gunaratnam, L., & Bonventre, J. V. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070804 · Cited by 178
Tempé, D., Piechaczyk, M., & Bossis, G. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360874 · Cited by 168
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 157
Olson, N. C., & van der Vliet, A. (2011) · Nitric Oxide · doi:10.1016/j.niox.2010.12.010 · Cited by 161
Speer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I. G., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 157
Transient Global Cerebral Ischemia Induces a Massive Increase in Protein Sumoylation
Yang, W., Sheng, H., Warner, D. S., & Paschen, W. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600523 · Cited by 140
Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer
Lundgren, K., Holm, C., & Landberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7390-6 · Cited by 142
Albanese, A., Daly, L. A., Mennerich, D., Kietzmann, T., & Sée, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010268 · Cited by 136
Zhang, J., Yao, M., Xia, S., Zeng, F., & Liu, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00682-7 · Cited by 150
SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity
Berta, M., Mazure, N. M., Hattab, M., Pouysségur, J., & Brahimi-Horn, M. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.103 · Cited by 125
The Ubiquitin Ligase Siah2 and the Hypoxia Response
Nakayama, K., Qi, J., & Ronai, Z. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0458 · Cited by 124
Yuan, R., Wang, K., Hu, J., Chen, Y., Li, M., Yu, X., Liu, X., Lei, J., Guo, W.-H., Wu, L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0284 · Cited by 119
Emerging roles of desumoylating enzymes
Kim, J. H., & Baek, S. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.008 · Cited by 119
mRNA-to-protein translation in hypoxia
Chee, N. T., Lohse, I., & Brothers, S. P. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0968-4 · Cited by 115
Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation
Liu, X., Chen, Z., Xu, C., Leng, X., Cao, H., Ouyang, G., & Xiao, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv379 · Cited by 112
Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Oliver, L., Olivier, C., Marhuenda, F., Campone, M., & Vallette, F. M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902030263 · Cited by 104
HIF-1α: a Valid Therapeutic Target for Tumor Therapy
Hong, S., Lee, H., & Kim, K. (2004) · Cancer Research and Treatment · doi:10.4143/crt.2004.36.6.343 · Cited by 108
Self-citationMutation of SENP1/SuPr-2 Reveals an Essential Role for Desumoylation in Mouse Development
Yamaguchi, T., Sharma, P., Athanasiou, M., Kumar, A., Yamada, S., & Kuehn, M. R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5171-5182.2005 · Cited by 100
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
Kukkula, A., Ojala, V. K., Mendez, L., Sistonen, L., Elenius, K., & Sundvall, M. (2021) · Cancers · doi:10.3390/cancers13174402 · Cited by 94
RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2α
van Hagen, M., Overmeer, R., Abolvardi, S. S., & Vertegaal, A. C. O. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1157 · Cited by 92
Advances in the development of SUMO specific protease (SENP) inhibitors
Kumar, A., & Zhang, K. Y. J. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.03.001 · Cited by 91
Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia
Cassavaugh, J. M., Hale, S. A., Wellman, T. L., Howe, A. K., Wong, C., & Lounsbury, K. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23321 · Cited by 88
Ubiquitin–proteasome system as a modulator of cell fate
Thompson, S. J., Loftus, L. T., Ashley, M. D., & Meller, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.09.010 · Cited by 87
A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1α
Qutub, A. A., & Popel, A. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.03087 · Cited by 88
Pawlus, M. R., & Hu, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.018 · Cited by 85
Xu, Y., Zuo, Y., Zhang, H., Kang, X., Fei, Y., Yi, Z., Liu, M., Yeh, E. T. H., Chen, G., & Cheng, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164236 · Cited by 81
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Cai, Q., Verma, S. C., Kumar, P., Ma, M., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009720 · Cited by 76
SUMO1 promotes Aβ production via the modulation of autophagy
Cho, S., Yun, S., Jo, C., Lee, D., Choi, K. J., Song, J. C., Park, S. I., Kim, Y.-J., & Koh, Y. H. (2014) · Autophagy · doi:10.4161/15548627.2014.984283 · Cited by 76
Tian, P., Xu, Z., Guo, J., Zhao, J., Chen, W., Huang, W., Wang, M., Mi, C., Zhang, Y., Yang, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103073 · Cited by 71
PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia
Kang, X., Li, J., Zou, Y., Yi, J., Zhang, H., Cao, M., Yeh, E. T. H., & Cheng, J. (2010) · Oncogene · doi:10.1038/onc.2010.297 · Cited by 71
Sumoylation as a Signal for Polyubiquitylation and Proteasomal Degradation
Miteva, M., Keusekotten, K., Hofmann, K., Praefcke, G. J. K., & Dohmen, R. J. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_16 · Cited by 71
Ciria, M., García, N. A., Ontoria‐Oviedo, I., González‐King, H., Carrero, R., de la Pompa, J. L., Montero, J., & Sepúlveda, P. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0331 · Cited by 69
Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia
Agbor, T. A., Cheong, A., Comerford, K. M., Scholz, C. C., Bruning, U., Clarke, A., Cummins, E. P., Cagney, G., & Taylor, C. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115931 · Cited by 68
Schaible, E., Windschügl, J., Bobkiewicz, W., Kaburov, Y., Dangel, L., Krämer, T. J., Huang, C., Sebastiani, A., Luh, C., Werner, C. D., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12708 · Cited by 67
Lee, Y., Bernstock, J. D., Nagaraja, N., Ko, B., & Hallenbeck, J. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13643 · Cited by 68
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Shi, Y., & Gilkes, D. M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05537-0 · Cited by 81
Sumoylation: Implications for Neurodegenerative Diseases
Anderson, D. B., Zanella, C. A., Henley, J. M., & Cimarosti, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_16 · Cited by 63
Intracellular energy production and distribution in hypoxia
Flood, D., Lee, E. S., & Taylor, C. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105103 · Cited by 68
The Role of Sumoylation in the Response to Hypoxia: An Overview
Filippopoulou, C., Simos, G., & Chachami, G. (2020) · Cells · doi:10.3390/cells9112359 · Cited by 56
Yang, W., Sheng, H., Homi, H. M., Warner, D. S., & Paschen, W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05404.x · Cited by 55
Frank, S., Peters, M. A., Wehmeyer, C., Strietholt, S., Wunrau, C., Bertrand, J., Heitzmann, M., Hillmann, A., Sherwood, J., Seyfert, C., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202080 · Cited by 55
The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance
Meller, R. (2009) · The Neuroscientist · doi:10.1177/1073858408327809 · Cited by 52
Kim, H., Chung, H., Yoo, Y., Kim, I. H., Lee, J., Lee, M., & Kong, G. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0218 · Cited by 51
Wang, X., Liang, X., Liang, H., & Wang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26342 · Cited by 51
Womeldorff, M. R., Gillespie, D. L., & Jensen, R. L. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.9.focus14496 · Cited by 51
SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α
Ao, Q., Su, W., Guo, S., Cai, L., & Huang, L. (2015) · Scientific Reports · doi:10.1038/srep16396 · Cited by 49
Hypoxia‐inducible factors in metabolic reprogramming during sepsis
Vanderhaeghen, T., Vandewalle, J., & Libert, C. (2020) · FEBS Journal · doi:10.1111/febs.15222 · Cited by 47
Chen, H., Ma, D., Yue, F., Qi, Y., Dou, M., Cui, L., & Xing, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210729123137 · Cited by 51
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications
Gu, Y., Fang, Y., Wu, X., Xu, T., Hu, T., Xu, Y., Ma, P., Wang, Q., & Shu, Y. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00420-3 · Cited by 51
Hirota, K. (2020) · Biomedicines · doi:10.3390/biomedicines8020032 · Cited by 52
Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity
Oh, S.-M., Liu, Z., Okada, M., Jang, S.-W., Liu, X., Chan, C.-B., Luo, H., & Ye, K.-N. (2009) · Oncogene · doi:10.1038/onc.2009.411 · Cited by 47
Bernstock, J. D., Ye, D., Gessler, F. A., Lee, Y.-J., Peruzzotti-Jametti, L., Baumgarten, P., Johnson, K. R., Maric, D., Yang, W., Kögel, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07631-9 · Cited by 46
Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition
Li, C., Fu, C., Zhou, W., Li, H., Liu, Z., Wu, G., He, T., Shen, M., & Liu, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02366-x · Cited by 60
Daly, L. A., Brownridge, P., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective
Gourevitch, D., Kossenkov, A. V., Zhang, Y., Clark, L. D., Chang, C., Showe, L. C., & Heber‐Katz, E. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0528 · Cited by 46
Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway
Manolescu, B. N., Oprea, E., Buşu, C., & Cercasov, C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.08.005 · Cited by 46
Molecular targets underlying SUMO‐mediated neuroprotection in brain ischemia
Silveirinha, V., Stephens, G., & Cimarosti, H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12347 · Cited by 43
Jiang, Y., Wang, J., TIAN, H., Li, G., Zhu, H., Liu, L., Hu, R., & Dai, A. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2209 · Cited by 41
Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma
Zhao, H., Wu, Y., Yang, C., & Liu, H. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0848-x · Cited by 40
Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids
Lin, X., Wang, Y., Jiang, Y., Xu, M., Pang, Q., Sun, J., Yu, Y., Shen, Z., Lei, R., & Xu, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117859 · Cited by 39
Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF‐1α fragments in vitro
Murray-Rust, T. A., Oldham, N. J., Hewitson, K. S., & Schofield, C. J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.012 · Cited by 41
Sener, Z., Cederkvist, F. H., Volchenkov, R., Holen, H. L., & Skålhegg, B. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160291 · Cited by 39
Lee, J. E., Shin, S.-H., Shin, H., Chun, Y., & Park, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39843-6 · Cited by 39
Self-citationAdenosine Signaling Mediates SUMO-1 Modification of IκBα during Hypoxia and Reoxygenation
Liu, Q., Li, J., Khoury, J., Colgan, S. P., & Ibla, J. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809275200 · Cited by 38
HIF signaling: A new propellant in bone regeneration
Bai, H., Wang, Y., Zhao, Y. D., Chen, X., Xiao, Y. M., & Bao, C. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212874 · Cited by 37
Lu, Z. H., Wright, J. D., Belt, B. A., Cardiff, R. D., & Arbeit, J. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061138 · Cited by 36
Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC
Guo, Y., Wang, J., Zhou, K., Lv, J., Wang, L., Gao, S., Keller, E. T., Zhang, Z., Wang, Q., & Yao, Z. (2020) · The FASEB Journal · doi:10.1096/fj.201903266rr · Cited by 36
Cardiac function and disease: emerging role of small ubiquitin‐related modifier
Wang, J. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.130 · Cited by 35
Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 35
Xiao, W., Geng, W., Zhou, M. L., Xu, J., Wang, S., Huang, Q., Sun, Y., Li, Y., Yang, G., & Jin, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04857-y · Cited by 33
Liu, X., Deng, H., Tang, J., Wang, Z., Zhu, C., Cai, X., Rong, F., Chen, X., Sun, X., Jia, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05008-z · Cited by 35
Wang, Y. E., Pernet, O., & Lee, B. (2011) · Biology of the Cell · doi:10.1111/boc.201100105 · Cited by 32
Lin, Y., Wang, M.-J., Xiao, Z., & Jiang, Z. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119432 · Cited by 33
Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma
He, W., Huang, L., Shen, X., Yang, Y., Wang, D., Yang, Y. W., & Zhu, X. (2016) · Gene · doi:10.1016/j.gene.2016.12.012 · Cited by 33
SUMOylation as a Therapeutic Target for Myocardial Infarction
Zhao, W., Zhang, X., & Rong, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701583 · Cited by 33
SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion
Rajan, S., Torres, J., Thompson, M. S., & Philipson, L. H. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00486.2011 · Cited by 32
Metadata
- Authors
- Bae, S.-H., Jeong, J.-W., Park, J. A., Kim, S.-H., Bae, M.-K., Choi, S.-J., & Kim, K.-W.
- Affiliations
- Seoul National University (KR)
- Harvard University (US)
- Pusan National University (KR)
- Corresponding author
- Kim, Kyu-Won
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 324
- Issue
- 1
- Pages
- 394-400
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2085483520
- Cited by
- 232
- References
- 26
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 15 · 2023: 8 · 2022: 12 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 11 · 2014: 16 · 2013: 12 · 2012: 8
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- HIF-1α, SUMOylation, SUMO1, protein stability, transcriptional activity, lysine modification, post-translational modification, ARNT, oxygen sensing, lysine mutants
- MeSH terms
- Amino Acid Sequence, Animals, Enzyme Stability, HeLa Cells, Humans, Lysine, Molecular Sequence Data, Protein Processing, Post-Translational, Transcription Factors, Transcription, Genetic, Gene Expression Regulation, Enzymologic, SUMO-1 Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review